July 31, 2008 – The U.S. Senate introduced a bill to permit lawsuits brought by patients who are injured by certain medical devices. This bill is directly intended to reverse the Supreme Court decision Riegel v. Medtronic Inc., in which the Court held that medical device companies are shielded from lawsuits for defective medical devices. The bill, named the Medical Device Safety Act of 2008, was introduced by Senator Edward M. Kennedy, Chairman of the Senate Health, Education, Labor and ...
continue reading...Iraq War Contractor Litigation
Posted July 22, 2008 in Legal Issues | Product News and Recalls
Iraq War Contractor Litigation – Lopez McHugh represents the families of nineteen civilian truck drivers, employees of Halliburton, who were killed in Iraq. These lawsuits had previously been dismissed by the District Court for the Southern District of Texas, but the Court of Appeals for the Fifth Circuit reversed that decision and remanded the cases for trial. The cases are now expected to go to trial in September of 2009.
The Court of Appeals’ Opinion can be ...
continue reading...Medical Device Safety Act of 2008
Posted June 29, 2008 in Drug and Medical Device Lawsuits | Health | Legal Issues | Product Liability | Product News and Recalls
June 29, 2008 – U.S. Representatives Frank Pallone, Jr. (D-NJ) and Henry A. Waxman (D-CA) have introduced legislation named the Medical Device Safety Act of 2008, a direct response to a recent decision by the United States Supreme Court that would provide immunity for manufacturers of defective medical devices.
In February of 2008, the Supreme Court issued an opinion entitled Riegel v. Medtronic, Inc., in which the Court held that the Medical Device Amendments of 1976 preempt state lawsuits brought by ...
continue reading...Mealey’s™ Pharmaceutical
Litigation SuperConference
A Plaintiff’s Bar Discussion
June 23 -25, 2008 • Embassy Suites Chicago – Downtown / Lakefront, Chicago
Chair:
Ramon Lopez, Esq., Lopez McHugh, LLP, Newport Beach, CA
Agenda and Networking Events
Monday, June 23, 2008
8:00 Registration & Continental Breakfast
9:00 Welcome & Introductory Remarks
Ramon Lopez, Esq., Lopez McHugh, LLP, Newport Beach, CA
9:15 Bextra® Litigation
• Litigation update
• Latest studies and reports
• MDL — individual, medical monitoring and third-party complaints
• Future of the ...
continue reading...On 5/16/2008 the FDA issued an alert for users of the immunosuppresants Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic). These drugs are commonly prescribed after organ transplants to prevent organ rejection, and have also been prescribed for immunemediated conditions such as systemic lupus erythematosus (SLE) and erythema multiforme.
CHILDREN BORN WITH BIRTH DEFECTS
These medications have led to reports of infants born with serious birth defects, including microtia (deformity of the outer ear) and cleft lip and palate. ...
continue reading...On 5/16/2008 the FDA issued an alert for users of the immunosuppresants Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic). These drugs are commonly prescribed after organ transplants to prevent organ rejection, and have also been prescribed for immunemediated conditions such as systemic lupus erythematosus (SLE) and erythema multiforme.
Children Born With Birth Defects
These medications have led to reports of infants born with serious birth defects, including microtia (deformity of the outer ear) and cleft lip and palate. ...
continue reading...
